Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 50,000 shares at $15.06 ($740K) on 2019-02-15, disclosed to the SEC on 2019-02-20.
Open-market sale of $740k COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.71 | 17,932 | $264K | 35.6% |
| 2 | $14.71 | 17,932 | $264K | 35.6% |
| 3 | $15.06 | 7,068 | $106K | 14.4% |
| 4 | $15.06 | 7,068 | $106K | 14.4% |
| Total | $14.81 avg | 50,000 | $740K | 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |